上海普惠金融顾问制度下沉，搭建金融与生物医药产业深度对接“桥梁”

Core Viewpoint - The biopharmaceutical industry is a key focus for Shanghai, with efforts to enhance financial integration and support for this sector through initiatives like the Inclusive Finance Advisory System [1][2] Group 1: Industry Development - Shanghai's Minhang District has over 900 biopharmaceutical companies, covering the entire pharmaceutical service chain, with Pujiang Town being a significant growth area [1] - The district's financial support has expanded from working capital to fixed asset loans, significantly reducing overall financing costs for enterprises, especially in foreign trade [1] Group 2: Financial Support Initiatives - The Inclusive Finance Advisory System, launched in September 2022, aims to bridge the information gap between financial institutions and enterprises, providing services like financial diagnosis and financing planning [1][2] - The Shanghai Financial Industry Association has optimized this advisory system to enhance service delivery and improve financing channels for businesses [2] Group 3: Company Financing Needs - Biopharmaceutical companies expressed urgent needs for financial support, highlighting the long product development cycles and challenges in securing loans without prior profitability [2] - Specific financing strategies discussed include policy-based financing guarantees and the introduction of non-financial factors in credit assessments for technology companies [2]